Ignite Creation Date:
2025-12-24 @ 4:56 PM
Ignite Modification Date:
2025-12-28 @ 3:21 PM
Study NCT ID:
NCT01032850
Status:
TERMINATED
Last Update Posted:
2021-06-02
First Post:
2009-12-14
Is NOT Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Sorafenib With Capecitabine for Patients With Measurable Hepatocellular Carcinoma
Sponsor:
New Mexico Cancer Research Alliance
Organization:
Organization Data
Organization:
Class:
OTHER
Study ID:
INST 0820
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
OTHER
Responsible Party:
Responsible Party Title:
Responsible Party Type:
SPONSOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None
Collaborators
Collaborators
| Name | Class | View |
|---|---|---|
| None | INDUSTRY | View |